Danchen Wu

8PUBLICATIONS
48CO-AUTHORS
Metabolic medicineHaematological tumoursMolecular targetsRespiratory diseasesPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 03, 2026
Author Correction: Mitochondrial fission links ECM mechanotransduction to metabolic redox homeostasis and metastatic chemotherapy resistance.

|Apr 28, 2026
Dynamin 2 Regulates Mitochondrial Mitotic Fission in Pulmonary Hypertension.

|Apr 09, 2026
SARS-CoV-2 targets mitochondria, exacerbating COVID-19 pneumonia.

Danchen Wu, Asish Dasgupta, Jaskaran Singh Hora

|Aug 29, 2025
Germline and somatic variants in DNMT3A and other clonal haematopoiesis of indeterminate potential genes contribute to pulmonary arterial hypertension.

Ruaa Al-Qazazi, Isaac M Emon, François Potus

|Aug 20, 2024
Novel Drp1 GTPase Inhibitor, Drpitor1a: Efficacy in Pulmonary Hypertension.

Danchen Wu, Ross D Jansen-van Vuuren, Asish Dasgupta

|Jan 08, 2024
Efficacy of Drpitor1a, a Dynamin-Related Protein 1 inhibitor, in Pulmonary Arterial Hypertension.

Danchen Wu, Ross D Jansen-van Vuuren, Asish Dasgupta

Pageof 2

Frequent Collaborators

5 joint publications

Asish Dasgupta

5 joint publications

Patricia D A Lima

5 joint publications

Stephen L Archer

4 joint publications

Jeffrey D Mewburn